TY - JOUR
T1 - Adherence to the Mediterranean Diet and Obesity-Linked Cancer Risk in EPIC
AU - Aguilera-Buenosvinos, Inmaculada
AU - Morales Berstein, Fernanda
AU - González-Gil, Esther M
AU - Dossus, Laure
AU - Gunter, Marc J
AU - Biessy, Carine
AU - Masala, Giovanna
AU - Santucci De Magistris, Maria
AU - Laouali, Nasser
AU - Shah, Sanam
AU - Marques, Chloé
AU - Heath, Alicia K
AU - Tsilidis, Konstantinos K
AU - Cross, Amanda J
AU - Ferrari, Pietro
AU - Castro-Espin, Carlota
AU - Debras, Charlotte
AU - Tumino, Rosario
AU - Tjønneland, Anne
AU - Halkjær, Jytte
AU - Drake, Isabel
AU - Ericson, Ulrika
AU - Guevara, Marcela
AU - Rodríguez-Barranco, Miguel
AU - Skeie, Guri
AU - Braaten, Tonje
AU - Gram, Inger Torhild
AU - Dahm, Christina C
AU - Agnoli, Claudia
AU - Schulze, Matthias B
AU - Huerta, José María
AU - Martínez-González, Miguel Ángel
AU - Huybrechts, Inge
AU - Toledo Atucha, Estefania
PY - 2025
Y1 - 2025
N2 - IMPORTANCE: Adherence to the Mediterranean Diet (MedDiet) has been associated with a lower incidence of cancer and reduced weight gain. These associations suggest a potential role for the MedDiet in lowering the risk of obesity-related cancers (ORCs). Obesity is a known risk factor for various cancers and shows an inverse association with MedDiet adherence.OBJECTIVE: To examine the association between adherence to the MedDiet and the risk of ORCs, considering the possible mediating role of adiposity.DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study analyzed data from the European Prospective Investigation Into Cancer and Nutrition (EPIC) study, which enrolled participants aged 35 to 70 years from 1992 to 2000 across 23 centers in 10 countries. The data analysis was conducted from March 1 to May 31, 2023.EXPOSURES: Dietary intake before baseline was evaluated using country-specific, validated questionnaires administered at recruitment. Adherence to the MedDiet was scored on a 9-point scale and categorized as low (0-3 points), medium (4-6 points), or high (7-9 points).MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of ORCs, classified according to the 2015 International Agency for Research on Cancer criteria. Multivariable Cox proportional hazards regression models were used to assess the association between MedDiet adherence and ORC incidence. Mediation analyses were conducted to evaluate the role of waist to hip ratio and body mass index in this association.RESULTS: A total of 450 111 participants were included in the study (mean [SD] age, 51.1 [9.8] years; 70.8% women) and followed up during a median (IQR) time of 14.9 (4.1) years. Among participants, 4.9% experienced an ORC (rates, 0.053, 0.049, and 0.043 per person-year in the low, medium, and high MedDiet adherence groups, respectively). Participants with high adherence to the MedDiet (7-9 points) had a lower risk of ORC compared with those with low adherence (0-3 points) (hazard ratio [HR], 0.94; 95% CI, 0.90-0.98). A similar inverse association was observed for participants with medium adherence (4-6 points vs 0-3 points). However, mediation analyses did not show associations of waist to hip ratio or body mass index between MedDiet adherence and ORC risk.CONCLUSIONS AND RELEVANCE: These findings indicate that higher adherence to the MedDiet is associated with a modest reduction in the risk of ORCs, independent of adiposity measures. Further research is needed to clarify the mechanisms by which the MedDiet may contribute to cancer prevention.
AB - IMPORTANCE: Adherence to the Mediterranean Diet (MedDiet) has been associated with a lower incidence of cancer and reduced weight gain. These associations suggest a potential role for the MedDiet in lowering the risk of obesity-related cancers (ORCs). Obesity is a known risk factor for various cancers and shows an inverse association with MedDiet adherence.OBJECTIVE: To examine the association between adherence to the MedDiet and the risk of ORCs, considering the possible mediating role of adiposity.DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study analyzed data from the European Prospective Investigation Into Cancer and Nutrition (EPIC) study, which enrolled participants aged 35 to 70 years from 1992 to 2000 across 23 centers in 10 countries. The data analysis was conducted from March 1 to May 31, 2023.EXPOSURES: Dietary intake before baseline was evaluated using country-specific, validated questionnaires administered at recruitment. Adherence to the MedDiet was scored on a 9-point scale and categorized as low (0-3 points), medium (4-6 points), or high (7-9 points).MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of ORCs, classified according to the 2015 International Agency for Research on Cancer criteria. Multivariable Cox proportional hazards regression models were used to assess the association between MedDiet adherence and ORC incidence. Mediation analyses were conducted to evaluate the role of waist to hip ratio and body mass index in this association.RESULTS: A total of 450 111 participants were included in the study (mean [SD] age, 51.1 [9.8] years; 70.8% women) and followed up during a median (IQR) time of 14.9 (4.1) years. Among participants, 4.9% experienced an ORC (rates, 0.053, 0.049, and 0.043 per person-year in the low, medium, and high MedDiet adherence groups, respectively). Participants with high adherence to the MedDiet (7-9 points) had a lower risk of ORC compared with those with low adherence (0-3 points) (hazard ratio [HR], 0.94; 95% CI, 0.90-0.98). A similar inverse association was observed for participants with medium adherence (4-6 points vs 0-3 points). However, mediation analyses did not show associations of waist to hip ratio or body mass index between MedDiet adherence and ORC risk.CONCLUSIONS AND RELEVANCE: These findings indicate that higher adherence to the MedDiet is associated with a modest reduction in the risk of ORCs, independent of adiposity measures. Further research is needed to clarify the mechanisms by which the MedDiet may contribute to cancer prevention.
KW - Humans
KW - Diet, Mediterranean/statistics & numerical data
KW - Middle Aged
KW - Female
KW - Male
KW - Neoplasms/prevention & control
KW - Obesity/epidemiology
KW - Prospective Studies
KW - Adult
KW - Aged
KW - Europe/epidemiology
KW - Risk Factors
KW - Incidence
KW - Patient Compliance/statistics & numerical data
KW - Body Mass Index
KW - Proportional Hazards Models
U2 - 10.1001/jamanetworkopen.2024.61031
DO - 10.1001/jamanetworkopen.2024.61031
M3 - Journal article
C2 - 39998833
SN - 2574-3805
VL - 8
JO - JAMA network open
JF - JAMA network open
IS - 2
M1 - e2461031
ER -